Neuroendocrine tumors are usually slowly growing neoplasms, which arise in the gastrointestinal tract, endocrine pancreas, lungs, or thymus. A majority are malignant. The most frequent location for distant metastases is the liver, and liver failure is the most common cause of death. Hence, in order to improve the prognosis in these patients, there is a need for better treatment of liver involement.

We invite investigators to contribute original research papers as well as review articles that will stimulate the understanding and progress of treatment of liver metastases in patients with neuroendocrine tumors. Potential topics include, but are not limited to:

• Surgical treatment of liver metastases
• Radiofrequency ablation
• Liver transplantation
• Liver embolization and chemoembolization
• Radioembolization
• Peptide receptor radionuclide therapy
• Chemotherapy
• Biotherapy
• Newer therapies
• MicroRNA-regulated pathways in neuroendocrine tumors

Articles published in this special issue will not be subject to the journal's Article Processing Charges.

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ijhep/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable: